LMT
47
7
SYF
65
-6
BAX
30
-3
HSY
40
2
IFF
56
-3
PDCO
54
-4
IR
72
-5
CHD
54
6
URI
58
-5
LNC
52
2
AEP
58
2
CME
42
-4
MCHP
43
-6
MS
64
7
KMI
59
2
HBI
62
4
NTRS
49
-5
MSI
72
2
FIS
46
-4
IPG
39
-3
LMT
47
7
SYF
65
-6
BAX
30
-3
HSY
40
2
IFF
56
-3
PDCO
54
-4
IR
72
-5
CHD
54
6
URI
58
-5
LNC
52
2
AEP
58
2
CME
42
-4
MCHP
43
-6
MS
64
7
KMI
59
2
HBI
62
4
NTRS
49
-5
MSI
72
2
FIS
46
-4
IPG
39
-3
Financhill
Back

Sequans Communications SA Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
41

SQNS
Sequans Communications SA

Last Price:
1.01
Seasonality Move:
-13.78%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
41
Sequans Communications SA (SQNS) is a Sell

Is Sequans Communications SA a Buy, Sell or Hold?

  • The current Sequans Communications SA [SQNS] share price is $1.01. The Score for SQNS is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • SQNS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

SQNS Stock Price Chart

What is Sequans Communications SA's stock price today?

  • The Sequans Communications SA share price today is $1.01
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SQNS is experiencing slight buying pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

SQNS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.08 Buy
Relative Strength Index (14 RSI): 59.96 Buy
Chaikin Money Flow: 10774 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.73 - 1.13) Buy
Bollinger Bands (100): (0.44 - 0.84) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

SQNS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1 Buy
20-day SMA: 1.02 Sell
50-day SMA: 0.72 Buy
200-day SMA: 1.21 Sell
8-day EMA: 1 Buy
20-day EMA: 0.95 Buy
50-day EMA: 0.81 Buy
200-day EMA: 1.15 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

Sequans Communications SA Earnings Growth & SQNS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.06 per share, an increase next quarter of $0.09 per share, a decrease this year of $0.15 per share, and an increase next year of $0.23 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Sequans Communications SA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):